2025 KoNECT-MOHW-MFDS International Conference (KIC) Meet Avance in Seoul

Meet Avance Clinical at 2025 KoNECT-MOHW-MFDS International Conference (KIC)

Avance Clinical is proud to announce our participation in the 2025 KoNECT-MOHW-MFDS International Conference (KIC) — Asia’s largest clinical trial conference, now celebrating its 11th year. Co-hosted by the Ministry of Health and Welfare (MOHW) and the Ministry of Food and Drug Safety (MFDS), KIC attracts over 1,500 attendees annually from government, academia, and the global life sciences industry.

This prestigious conference is a premier platform for biotech and pharma companies to explore emerging trends, regulatory developments, and innovations shaping the future of clinical trials across Asia and around the world.

Why Meet Us at KIC?

Avance Clinical is a globally integrated CRO delivering clinical trial solutions across Australia/New Zealand, Asia, North America, Europe. Our presence in South Korea is expanding rapidly to support growing demand from biotech sponsors seeking accelerated timelines, regulatory expertise, and global trial readiness.

KIC 2025 offers a unique opportunity to:

• Meet our regional and global leadership team
• Learn about our Asia Advantage, including rapid start-up and access to high-quality data
• Explore how our global model supports biotech sponsors from early to Late phase trials
• Connect with our careers team to explore new opportunities in our Asia operations